Home > Insider Trading > Filing (0000899243-19-017621)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1512762	Coherus Biosciences Inc.	CHRS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1427569	Jean-Frederic Viret	Coherus Biosciences, Inc. 333 Twin Dolphin Drive, Suite 600 Redwood City CA 94065	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $0.0001 Par Value	Disposition	2019-06-18	3,000	$19.31	12,180	No	4	S	Direct
Common Stock, $0.0001 Par Value	Disposition	2019-06-19	667	$20.00	11,513	No	4	S	Direct
Common Stock, $0.0001 Par Value	Acquisiton	2019-06-19	3,159	$10.05	14,672	No	4	M	Direct
Common Stock, $0.0001 Par Value	Disposition	2019-06-19	3,059	$20.32	11,613	No	4	S	Direct
Common Stock, $0.0001 Par Value	Disposition	2019-06-19	100	$20.81	11,513	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-06-19	3,159	$0.00	3,159	$10.05

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
126,841		2028-02-01	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person.
The transaction was executed in multiple trades in prices ranging from $19.04 to $19.69, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
Includes 1,995 shares acquired on May 15, 2019 pursuant to Issuer's employee stock purchase plan.
The transaction was executed in multiple trades in prices ranging from $19.75 to $20.75, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.